Podcasts about pokitdok

He had Steve Jobs and Bill Gates as Mentors in the Same Year.Get inspired by Ted Tanner, CIO of Big Bear.ai, who shares his incredible personal journey that literally changed the world.Discover the “TAO of Tech Leadership”...how the natural order of human wisdom and tech can harmoniously come together.He's like the Rick Rubin of Sound and Technology. There's so much to absorb here from the distilled wisdom of the incredible lineage of his mentors like Steve Job, Bill Gates, and so many others. He's on the bleeding edge of sound, tech, and Machine Learning, and you'll want to hear his predictions where it's all headed.It's poignant, metaphysical, and stretches the imagination about what's possible.Ted's motto is “Ship Software, Change The World”.BigBear.ai's mission is to deliver clarity for the world's most complex decisions. BigBear.ai's AI-powered, decision intelligence solutions are leveraged in three core markets: global supply chains & logistics, autonomous systems and cyber. Their customer's include BigBear.ai's customers, which include the US Intelligence Community, Department of Defense, and the US Federal Government.He's also served in senior leadership roles at companies like IBM (CTO and Chief Architect - Watson Health), Co-Founder and CTO PokitDok, Apple, and Microsoft.LinkedIn Profile https://www.linkedin.com/in/theodoretanner/Company Link: https://bigbear.ai/Personal Website: http://www.tedtanner.org/ What You'll Discover in this Episode:How a catastrophic injury became a pivotal moment.Steve Jobs and Bill Gates - What he learned working for both.The very first meeting he had with Steve Jobs.Ted's approach to finding great mentors.Why he used rejection letters as wallpaper.What it takes to become a leading CTO.Why leaders must become technical AND strategic.Machine learning - What leaders need to do now.Resources:The Courage to Create - Rollo May-----Connect with the Host, #1 bestselling author Ben FanningSpeaking and Training inquiresSubscribe to my Youtube channelLinkedInInstagramTwitter

As a country, we spend approximately $500 billion on prescription drugs. Specialty drugs account for less than 2% of prescriptions but will cost us over $250 billion (that's in 2021)—so, 2% of prescriptions but half the spend. Specialty is the fastest-growing segment of healthcare spend and is a dominant issue that self-funded employers and other purchasers face. But let's dig into that $250 billion being spent on specialty drugs, shall we? I have to say, personally, that if we spent $250 billion but saved more than that in medical costs or if the patient quality of life went up measurably or if life expectancy or overall survival or whatever metric you used to assess quality … if that big spend produced even bigger returns/results, I for one would be like, “OK, trade-offs. Let's discuss.” But the thing is, clinical trials and real-world evidence alike suggest that there's a lot of patients who don't really benefit from the expensive drugs that they are taking or were prescribed, and even those who benefit might not get the results that they're hoping for or even de minimis expecting. In this healthcare podcast, I am talking with Pramod John, CEO of VIVIO Health; and he makes a couple of great points about all of this that I'll repeat here and then he's gonna say them again later in this episode but in context—and probably better. There was some research done that showed for a really popular, really expensive drug, only 2% of patients who took it got the expected, maybe promised, benefits. But 100% of the patients who took that drug got bad, in some cases dangerously bad, diarrhea. This situation is really kind of typical. A drug will work great for some people, mediocre for other people/patients, and not at all for, say, the remaining what might be majority of patients. So, you'll have 2 patients where the results are out of the park, 23 patients where results are pretty darn good, 25 patients reporting meh results but something you can actually still point to, and then maybe 50 patients who see absolutely no improvement in anything. So, here's an important point: Maybe there's, let's just say, 3 drugs or 10 drugs in this therapeutic category, and that same patient distribution is true for all of them—except different drugs may work for different people. So, by enabling access to all the drugs, you can see that patients have a better chance of being in one of those first groups where they actually get results because there's more drugs that they can try and different drugs work differently in different people. But now, let's consider the way that we pay for specialty drugs: One or two of them get on formulary typically, and then all the others are excluded. That said, the purchaser, patient, and/or taxpayer is gonna pay a whole lot of money for those drugs regardless of how well they do or do not work. And with fewer drugs on formulary, there's less of a chance that results gold will be struck. But we're gonna pay a whole lot of money, also in terms of human life, to deal with the direct and cascading side effects of drugs whether they do or don't work. I have to admit, I kind of have a new appreciation for so-called me-too drugs after this conversation. Let me just add that here for the record. My guest today and next week is Pramod John, who is the founder and CEO over at VIVIO Health. VIVIO contracts with self-insured employers and helps their employees/members/patients (whatever you call them) get the right drug. They actually expand access, and the employer saves money. After what I just said, you might be cottoning on to why. The show this week concerns the reality of specialty drugs and what the terms efficacy and effectiveness really mean because they might not mean what you think they mean. As inconceivable as that might feel, I learned something. You might, too. And there are implications—big implications—for all of this for patients/members/employees. Or you and your family. In this episode, we also define and discuss the terms NNT (number needed to treat) and NNH (number needed to harm), which are really important and, in my humble opinion, do not get discussed enough—especially with patients who need to know these things to make informed choices. Next week's show is also with Pramod John, and we get into how what we talk about here intersects with rebates and formularies. Come back for that. It's probably a 400-level class in specialty pharmacy rebating, but some of you will appreciate it. You can learn more at viviohealth.com or by emailing Pramod at pramod@viviohealth.com.   Pramod John, PhD, is the team leader of VIVIO, a public benefit corporation whose mission is to ensure that drugs work in the real world for the people on them and that their costs reflect the value provided. VIVIO's model has improved health outcomes and generated 35% to 40% savings on drug acquisition costs. It accomplishes this by answering three simple questions: (1) Is this the right drug? (2) Is it a fair price? and (3) Is it working for the patient? Before VIVIO, Pramod was founder of Oration PBC (acquired by PokitDok), which gave consumers control over their drug purchasing by capturing the prescription in the physician's office and providing real-time pricing options and automatic routing capabilities. Pramod was also vice president of strategy and innovation at McKesson, the world's largest healthcare company. At McKesson, Pramod helped develop solutions that leveraged advanced technologies and business process improvements to optimize healthcare delivery systems, infrastructure, and supply chains. Earlier, Pramod founded and served as CEO of PacketMotion, Inc, a venture-funded startup in the enterprise network information and policy management industry. VMware later acquired the company. In addition, Pramod founded netExaminer.com, a managed-vulnerability assessment company acquired by SonicWALL. Pramod earned his PhD in electrical engineering from the University of Illinois at Urbana-Champaign. He serves on the board of Wycliffe USA. He also serves on the advisory board of Folia Water and as a mentor at StartX. 05:34 What does a good response mean in pharmaceutical products? 06:06 “Different people get different utility out of something.” 06:31 Why doesn't efficacy mean what you think it means in terms of pharmaceutical products? 08:40 What is the difference between efficacy and effectiveness in Pharma? 09:10 Why aren't drugs' major side effects factored into a drug's efficacy and effectiveness? 10:14 “What's the benefit of this versus what's the harm in this?” 13:35 “Clearly as consumers, we all feel that we're special. But what about physicians?” 14:14 “The benefit itself—what does it have to be?” 15:18 EP334 with Sunita Desai, PhD.17:11 “We tend to think of things as a binary distribution—it works or it doesn't.” 18:22 “The default choice that we start with is often the wrong one.” 20:54 “It doesn't matter why if we can't fix the reason.” 22:02 “At some point, the question becomes, ‘Do we have any information?'” 22:36 Why do other developed countries pay less for their drugs? 24:21 How do we end up with crappy drugs on the market that don't really move the dial? 25:57 EP303 with Anna Kaltenboeck. 27:22 “We can build a better system. And that's what we do every day.” You can learn more at viviohealth.com or by emailing Pramod at pramod@viviohealth.com.   Pramod John discusses #specialtydrugpricing on our #healthcarepodcast. #healthcare #podcast #pharma #specialtypharma #specialtydrugs What does a good response mean in pharmaceutical products? Pramod John discusses #specialtydrugpricing on our #healthcarepodcast. #healthcare #podcast #pharma #specialtypharma #specialtydrugs “Different people get different utility out of something.” Pramod John discusses #specialtydrugpricing on our #healthcarepodcast. #healthcare #podcast #pharma #specialtypharma #specialtydrugs Why doesn't efficacy mean what you think it means in terms of pharmaceutical products? Pramod John discusses #specialtydrugpricing on our #healthcarepodcast. #healthcare #podcast #pharma #specialtypharma #specialtydrugs What is the difference between efficacy and effectiveness in Pharma? Pramod John discusses #specialtydrugpricing on our #healthcarepodcast. #healthcare #podcast #pharma #specialtypharma #specialtydrugs Why aren't drugs' major side effects factored into a drug's efficacy and effectiveness? Pramod John discusses #specialtydrugpricing on our #healthcarepodcast. #healthcare #podcast #pharma #specialtypharma #specialtydrugs “What's the benefit of this versus what's the harm in this?” Pramod John discusses #specialtydrugpricing on our #healthcarepodcast. #healthcare #podcast #pharma #specialtypharma #specialtydrugs “Clearly as consumers, we all feel that we're special. But what about physicians?” Pramod John discusses #specialtydrugpricing on our #healthcarepodcast. #healthcare #podcast #pharma #specialtypharma #specialtydrugs “The benefit itself—what does it have to be?” Pramod John discusses #specialtydrugpricing on our #healthcarepodcast. #healthcare #podcast #pharma #specialtypharma #specialtydrugs “We tend to think of things as a binary distribution—it works or it doesn't.” Pramod John discusses #specialtydrugpricing on our #healthcarepodcast. #healthcare #podcast #pharma #specialtypharma #specialtydrugs “The default choice that we start with is often the wrong one.” Pramod John discusses #specialtydrugpricing on our #healthcarepodcast. #healthcare #podcast #pharma #specialtypharma #specialtydrugs “It doesn't matter why if we can't fix the reason.” Pramod John discusses #specialtydrugpricing on our #healthcarepodcast. #healthcare #podcast #pharma #specialtypharma #specialtydrugs “At some point, the question becomes, ‘Do we have any information?'” Pramod John discusses #specialtydrugpricing on our #healthcarepodcast. #healthcare #podcast #pharma #specialtypharma #specialtydrugs Why do other developed countries pay less for their drugs? Pramod John discusses #specialtydrugpricing on our #healthcarepodcast. #healthcare #podcast #pharma #specialtypharma #specialtydrugs How do we end up with crappy drugs on the market that don't really move the dial? Pramod John discusses #specialtydrugpricing on our #healthcarepodcast. #healthcare #podcast #pharma #specialtypharma #specialtydrugs   Recent past interviews: Click a guest's name for their latest RHV episode! Dr Eric Bricker, Katy Talento, Stacey Richter (INBW33), Stacey Richter (INBW32), Dr Steve Schutzer (Encore! EP294), Lisa Trumble, Jeb Dunkelberger, Dr Ian Tong, Mike Schneider, Peter Hayes, Paul Simms, Dr Steven Quimby, Dr David Carmouche (EP343), Christin Deacon, Gary Campbell, Kristin Begley, David Contorno (AEE17), David Contorno (EP339), Nikki King, Olivia Webb, Brandon Weber, Stacey Richter (INBW30), Brian Klepper (AEE16), Brian Klepper (EP335), Sunita Desai, Care Plans vs Real World (EP333), Dr Tony DiGioia, Al Lewis

Ted Tanner Jr., CTO of Watson Health. Ted was previously the CTO of PokitDok (a major healthcare company which leveraged APIs and the DokChain blockchain platform). PokitDok was acquired by Change Healthcare in 2018. Ted is an engineering executive with extensive experience ranging from startups to public corporations. Focused mainly on growth scale computing he has held architect positions at both Apple and Microsoft and has held instrumental roles in several start-ups, including digidesign (IPO and acquired by Avid), Crystal River Engineering (acquired by Creative Labs), and more. He is on the IAB for the University of South Carolina Computer Science Department as well as the Center for Intelligent Systems and Machine Learning at the University of Tennessee. Ted's website: https://www.tedtanner.org/ IBM Watson Health website: https://www.ibm.com/watson-health Twitter: https://twitter.com/tctjr Topics Overview •Introduction of Ted's background •Journey into healthcare and technology •Experience starting PokitDok and selling to Change Healthcare •When did you first learn about blockchain? •How is blockchain adoption and awareness in healthcare developing globally and domestically? •Web3 •Are you concerned about the impact of quantum computing on the world's data security systems, especially blockchains? •Is the future of AI/ML/FL dependent on a secure blockchain network? •What excites you most about IBM Watson Health? •What is LinuxforHealth? Why is it important? •Regulation of technology •Young people and technology addiction •What advice can you share with young technology entrepreneurs who are looking to reshape the healthcare system? •Philosophical/Personal •What do you believe in that most people would disagree with? •(Not to get political) how can technology be used to address drug taboos in our society? •If it’s not too personal, what would you consider to be your biggest mistake? •Favorite book that has influenced you - How to Read a Book by Mortimer J. Adler •What are your thoughts about the singularity that is supposed to happen in 2045? •If you had to have micro chip implanted in your body, where would you want it to be implanted? •Key Takeaways News Corner On May 20, 2021, The Chopra Foundation, a non-profit organization dedicated to improving health and well-being, announced the availability of their new, free, Never Alone mobile application, which offers individuals the ability to connect, 24/7, with curated volunteers, counselors, mental health experts/professional, local organizations, and hospitals based on their location. The app is a collaboration with CG Creative Studios and leverages the Hedera network which is a decentralized ledger technology that uses acyclic graphs to create an asynchronous Byzantine Fault-Tolerant consensus algorithm. The hashgraph technology is currently patented, and the only authorized ledger is Hedera Hashgraph. The native cryptocurrency of the Hedera Hashgraph system is HBAR. The app allows mental health and wellness experts, from medical professionals to meditation experts, to upload content into a service registry, where it is logged on the Hedera Consensus Service and given a digital fingerprint, providing a guarantee of where that content resides and making it completely tamperproof. Users gain easy access by simply logging into the platform to view trustworthy content that they know has not been altered or falsified. The goal of the initiative is to address the roots of human stress and suffering, advance innovation based on scientific research, and democratize access to wellness resources and everyday tools for those in need. https://www.prnewswire.com/news-releases/chopra-foundation-launches-never-alone-app-powered-by-hedera-to-support-mental-and-emotional-well-being-301296334.html Health Unchained Links Website: https://healthunchained.org Telegram: t.me/healthunchained Twitter: twitter.com/Healthunchaind

Denise's choice for STEM and maths was a no brainer, but the rest of the journey wasn't as clear. There were many forks along the way. Denise first told us about her maths studies and how she inadvertedly discovered graphs theory. She described how her aversion for a focus on teaching led her to digging deeper into the graphs field that became the subject of her PhD. We the talked about moving from academia to the industry. Denise told us about her job at the startup PokitDok and how it felt to combine the rigor or data science with the willingness to move fast of the startup world. We brushed over her experience as an evangelist. And finally we talked about DataStax and Denise's role working on OpenSource, with Cassandra, the NoSQL movement and some of the most brilliant minds in the graph theory space. Denise finished by giving us two advices: don't be afraid to fail, and trust yourself!Here are the links of the show:https://www.twitter.com/DeniseKGosnellhttps://github.com/denisekgosnellGraph Technology Makes Teams More Productive https://medium.com/@denisekgosnell/graph-technology-makes-teams-more-productive-ebc549aa45fbGraph Book https://github.com/datastax/graph-bookThe Practitioner's Guide to Graph Data http://shop.oreilly.com/product/0636920205746.doMatthias Broecheler https://www.linkedin.com/in/matthiasbroechelerTed Tanner https://twitter.com/tctjrTeresa Haynes https://en.wikipedia.org/wiki/Teresa_W._HaynesCreditsMusic Aye by Yung Kartz is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.Your hostSoftware Developer‘s Journey is hosted and produced by Timothée (Tim) Bourguignon, a crazy frenchman living in Germany who dedicated his life to helping others learn & grow. More about him at timbourguignon.fr.Want to be next?Do you know anyone who should be on the podcast? Do you want to be next? Drop me a line: info@devjourney.info or via Twitter @timothep.Gift the podcast a ratingPlease do me and your fellow listeners a favor by spreading the good word about this podcast. And please leave a rating (excellent of course) on the major podcasting platforms, this is the best way to increase the visibility of the podcast:Apple PodcastsStitcherGoogle PlayPatreonFinally, if you want to help produce the podcast, support me on Patreon. Every cent you pledge will help pay the hosting bills!Thanks!Support the show (http://bit.ly/2yBfySB)

Featuring Lisa Maki Founder & CEO of PokitDok, Molly Moore healthplan lead of Decent, and Tony Little ND senior director of Optum360 This episode is a live recording of our TF Seattle Chapter event on June 11th, 2019 about healthcare & blockchain. In this panel we discuss the current state of health care and the technology systems in place, the pains of navigating healthcare and insurance from the patient, hospital, and provider perspective, how blockchain could be a potential solution and the likeness for the healthcare system to adopt, and the need for consortiums. Let us know what you thought after the show @TFBlockchain on Twitter, Linkedin, and Facebook.

Chrissa McFarlane experience as a laboratory research assistant 2007-2009 at the US dept of Agriculture and Albert Einstein College of Medicine 2005-2007 helped shape her perspective in the healthcare system. She studied Business and Africana studies, Spanish, Latin American studies/ global health at Cornell University. Wake forest university MA- business. Bronx High school She's an active leader at HIMSS and is part of their Blockchain in healthcare task force. She's also a mentor of Boomtown accelerators Patientory was founded by Chrissa in 2015 and raised $7.2 Million in 2017 via an initial coin offering. We talked about what it means to empower patients to own and manage their own medical records using blockchain technology. Admittedly, Chrissa doesn’t emphasize the word blockchain when speaking to healthcare executives because it tends to dissuade them. Patientory Association Website: Ptoy.org Patientory Corporation Site: Patientory.com Udemy Blockchain/Healthcare Course ($125 off with HEALTHUNCHAINED coupon): www.udemy.com/blockchain-and-hea…de=HEALTHUNCHAINED Topics Overview Chrissa McFarlane, Founder and CEO of Patientory- A peer-to-peer EMR Storage network. • Introduction of Chrissa's background and experience • Origins of Patientory and experience with startup incubators • How important is the peer-to-peer aspect of your company? • How does the app interact with hospital systems to get provider produced patient records? • What happens if Patientory no longer exists? Where does my data go? • Private key management- maybe body embedded RFID chips • Permissioned blockchains and cryptocurrency market • How can various stakeholders (Patients, providers, payers, pharma, and research) benefit in the Patientory ecosystem? • Smart contracts and insurance claims processing • Patientory Enterprise is still in development and will be released in 2019 • How much has the crypto bear market affected your company operations or goals? • How are blockchain companies changing traditional Business strategies? • Patientory is one of the first healthcare/blockchain companies having started in 2015. Did the early start help you stay ahead of other competitors doing similar projects? • HIPAA compliance and regulatory environment • PTOY token utility is to allow access to the network and allocate data storage • Patientory Association is currently run by Patientory ambassadors • Patientory sponsored the 2nd issue of the Journal of the British Blockchain Association • Adoption challenges • Patientory team and community culture • Roadmap News Corner The biggest story in the past couple weeks is McKesson’s Change Healthcare acquisition of Pokitdok. Pokitdok was founded in 2011 and provides its customers with a platform-as-a-service solutions including Identity, benefits, and claims management. Pokitdok’s solution run on a blockchain called Dokchain and is governed by the Dokchain Health Alliance. Change healthcare plans to integrate key PokitDok APIs into the Change healthcare intelligent healthcare network which will add new capabilities for digital health, telemedicine, and other new disruptive car models that support value-based, patient-centric healthcare. The Change Healthcare Intelligent Healthcare Network reaches approximately 2,200 government and commercial payer connections, 5,500 hospitals, 900,000 physicians, and 33,000 pharmacies. In the company’s fiscal year ended March 31, 2018, it facilitated nearly 14 billion healthcare transactions and $1.0 trillion in annual healthcare expenditures. Press Release: https://www.changehealthcare.com/press-room/press-releases/detail/change-healthcare-acquires-pokitdok-assets

I was thinking about this when reading that Forbes article that came out the other day that 44% of Americans skip doctor visits or medical care due to cost. Here's my point: There could be 2 prongs to this. One of them is that the costs are too high. And yep, they are. Even more distressing when you consider that only a dime on every dollar spent on health care goes to the physician or nurse or person actually providing the care. So much is chewed up by invisible middle people adding questionable value to patient care. But here's another prong that you might not have thought of. I remember in one of my marketing classes ages ago the case study about classified ads. Classified ads that listed the price were something like 50% more successful than those that did not. If there's no price, consumers just assume the price is too high. Consumers are consumers whether they're buying a used lawnmower or medical care, and they simply assume the cost is too high when the price tag is turned under. Buying something and being obligated to pay for it even if you don't know what you're getting yourself into... that's a risk that might be a factor in that 44% not bothering to show up for care they need. Today, I speak about the hidden costs and frictions in health care with Joe Murad, President and CEO of PokitDok. Costs and frictions that make being a health care consumer a less than optimal experience. Joe most recently served as Managing Director and Head of Individual Exchange Solutions for Willis Towers Watson where he was responsible for the largest private health insurance exchange. Prior to WTW, Joe was the COO and a founding team member of Extend Health, Inc. from its inception until its $435MM sale to Towers Watson in 2012. Before Extend Health, Joe was part of the initial team at eHealth (IPO: EHTH) where he served as the Director of Business Development and was instrumental in building the company's early overall success. Before eHealth, Joe held numerous market facing roles at Informix Software, Inc. (acquired by IBM in 2001) by way of its acquisition of Illustra Information Technologies in 1995. 00:00 Integrated delivery models. 04:30 Where Joe sees the biggest breakdowns in communication in health care. 05:00 “An ecommerce for health care.” 06:25 Stripping out unnecessary processes through intermediaries in health care. 10:00 The path to transformational change in health care. 13:00 What better transparency looks like, and how we get there. 13:40 “Health care skipped the Internet.” 16:10 What's possible today. 16:20 “You really have to look back in order to move forward.” 18:00 Joe's definition of a modern-day patient experience. 19:50 PokitDok's aim to rebuild everything. 20:40 Who hires PokitDok. 21:55 “We enable organizations.” 27:15 How PokitDok changes the consumer experience. 31:00 There's $250 billion in payer spend. 32:00 Joe's advice to organizations feeling pressure from big intermediaries with a lot of influence. 32:45 You can learn more at pokitdok.com

Wednesday, January 31st we close out the first Month in 2018 with a roundtable conversation of blockchain applications for the 3 trillion plus healthcare ecosystem. Transaction intensive and ripe with security, portability, affordabiity, access and quality issues via both siloed and centralized databases whether legacy server hosted or more recently via the cloud, the healthcare space seems a likely candidate for disruption given the promise or ‘hype of its disintermediation upside. In this session we'll explore blockchain technologies’ upside potential and attempt  to vet the signal from the noise. My guests include: Ted Tanner, Jr., co-founder and CTO of PokitDok, Dan Munro, a writer who lives outside of Phoenix, Arizona. He is authored and writes about technology, cybersecurity, and policy for a variety of online and print publications, and Tatyana Kanzaveli, investor, entrepreneur, CEO Open Health, TEDxBayArea organizer, creative thinker who likes technologies,cooking, hiking chess, arts, good people and wine! Join us!  

Pramod John is team leader of Vivio Health, a company that is reinventing the therapeutic use and supply chain for the specialty drug space. The Vivio Health plan solution is challenging the current framework of efficacy and extending it to true effectiveness in the real world. It also offers significant drug acquisition savings and simplicity for the patient by integrating the supply chain into a unified and data driven process. Prior to Vivio Health, Pramod was founder of Oration PBC (acquired by PokitDok) which was focused on giving back consumers control over their drug purchasing by capturing the prescription in the physician's office and providing real-time pricing options and automatic routing capabilities. Pramod was also VP of Strategy and Innovation at McKesson, the world's largest health care company. At McKesson, Pramod helped develop solutions that leveraged advanced technologies and business process improvements to optimize health care delivery systems, infrastructure, and supply chains. Earlier, Pramod founded and served as CEO of PacketMotion, Inc., a venture-funded startup in the enterprise network information and policy management industry. The company was later acquired by VMware. In addition, Pramod founded netExaminer.com, a managed-vulnerability assessment company acquired by SonicWALL (owned by Dell). Pramod earned his PhD in Electrical Engineering from the University of Illinois at Urbana-Champaign. He serves on the Boards of Mission Aviation Fellowship, a global relief organization, and 3Crosses Church in Castro Valley, CA. He also serves on the advisory board of Folia Water and as a mentor at StartX. 00:00 What aspects of health care that Vivio solves. 02:15 What would care look like by starting with the question, “What outcome do we want to see?” 04:40 Benefit designs. 06:00 Vivio's customers. 06:50 How this works from the patient side. 09:00 How this looks from a clinician standpoint. 13:00 Proactively building clinical models and data collection. 13:30 Results of Vivio's transparency. 14:45 How this comes down to a numbers problem. 15:00 “There's very little clinical to do in a clinical trial.” 17:00 The types of reports that Vivio comes up with, and who they benefit? 19:00 “How do we help people see, ‘Here are the one or two things you need to understand.” 22:30 You can learn more at www.viviohealth.com.

Pramod John is team leader of VIVIO Health, a company that is reinventing the therapeutic use and supply chain for the specialty drug space. VIVIO Health's solution is challenging the current framework of efficacy and extending it to true effectiveness in the real world. It also offers significant drug acquisition savings and simplicity for the patient by integrating the supply chain into a unified and data driven process. Prior to VIVIO Health, Pramod was founder of Oration PBC (acquired by Pokitdok) which was focused on giving back consumers control over their drug purchasing by capturing the prescription in the physician's office and providing real time pricing options and automatic routing capabilities.   Pramod was also VP of Strategy and Innovation at McKesson, the world's largest healthcare company. At McKesson, Pramod helped develop solutions that leveraged advanced technologies and business process improvements to optimize healthcare delivery systems, infrastructure and supply chains. Earlier, Pramod founded and served as CEO of PacketMotion, Inc., a venture-funded startup in the enterprise network information and policy management industry. The company was later acquired by VMWare. In addition, Pramod founded netExaminer.com, a managed-vulnerability assessment company acquired by SonicWALL (owned by Dell). Pramod earned his Ph.D. in Electrical Engineering from the University of Illinois at Urbana-Champaign. He serves on the Boards of Mission Aviation Fellowship, a global relief organization and 3 Crosses Church in Castro Valley, CA. He also serves on the advisory board of Folia Water and as a mentor at StartX. 00:00 Pramod's article on Amazon getting into Pharmacy & Stacey's Inbetweenisode 14. 00:45 The four key structural roadblocks Amazon would have to overcome to get into Pharmacy. 02:20 The issues in the pharmacy space & the hope that a disruptor can come in and fix these issues. 03:50 What Amazon would have to do to overcome the current issues in the drug market. 05:00 What innovation would Amazon have to bring to the market to truly be innovative? 07:00 The unmovable vested interests in the pharma industry. 08:15 The monopoly of the pharma industry on the micro level. 09:45 Why consumers go to Amazon. 10:15 The difference between the health care consumer market and other consumer markets. 11:10 The primary driver for consumers in the drug space. 12:20 The disjointed process of prescriptions and pharmacies. 13:15 What will lead to real disruption in this industry. 15:15 “Amazon doesn't just mean Amazon anymore.” 16:15 The difference Amazon has made in an unregulated market versus a regulated market. 17:00 “What are we going to do about these intermediaries?” 17:30 The economic problem in the pharma market. 17:45 The best strategy to completely change the dynamics of the industry. 18:10 Taking insurance, Getting in Network, E-Prescribing, Buying a PBM. 22:45 “You can't grow demand when three people control 70% of the market.” 28:50 The self-administered space. 30:15 “Disruption is going to come because we're getting ahead of where the money is coming from in the future.” 31:00 You can learn more at www.viviohealth.com.

Currently, 35-40% of medical data is unencrypted, and communication in the healthcare field is incredibly slow. PokitDok aims to fix that, by creating a healthcare API platform on the Ethereum blockchain that can securely and swiftly store and transmit medical information throughout the healthcare system. Their technology is used by over 600 insurance companies, 1000 third-party apps, and 95% of the tele-health field, and has all necessary compliances, including HIPAA. They have three main blockchain innovations–identity by consensus, autonomous auto adjudication, and supply chain management for pharmaceuticals–all with the ultimate goal of giving consumers control over their own private medical data. Their innovations have wide-ranging implications not on the in the healthcare field, but in the financial industry and beyond. For more information, visit www.pokitdok.com.

Part 2. Blockchain in healthcare is a rapidly growing niche, with companies like Hashed Health, Patientory and PokitDok leading innovation in the use of distributed ledger technology for electronic medical records and other applications. Blockchain, though not necessarily the right solution for every problem, is helping with issues in healthcare technology surrounding patient privacy, control of patient data, and health data security. Kristen Johns is a patent attorney at Waller Law, who works with clients on patent and trademark protection, data privacy and security matters, cybersecurity and cloud-related issues. In the past couple of years, she's been digging into blockchain as an emerging technology, looking at its applications and trajectory across industries including healthcare.

The Healthy Future podcast is a show about the incredible transformation happening in healthcare today and the progress we’re looking forward to seeing tomorrow. On today’s episode I’m joined by my colleague Rohan Kulkarni, vice president of strategy for Xerox Healthcare. We shine a spotlight on PokitDok, a company in the business of connecting people with the healthcare information they need. We also interview Andre Blackman, who works to connect the dots in the healthcare innovation landscape. The Healthy Future podcast is brought to you by Xerox Healthcare, where I serve as the chief innovation officer. If you enjoyed the show, please consider sharing it with your friends and colleagues! Show notes: - Healthcare news review begins at 1:57 - Xerox Open Enrollment survey results begins at 3:55 - Company Spotlight: PokitDok begins at 6:43 - Interview with Andre Blackman begins at 12:09 Show materials: - The Two Mysteries of Medicare: http://www.nytimes.com/2016/10/04/upshot/the-two-mysteries-of-medicare.html - Technology and Health Care: The View From HHS: http://www.wsj.com/articles/technology-and-health-care-the-view-from-hhs-1474855381 - Video Chat? In Rural Areas Combating Drug Addiction, A New Way To Connect With Help: http://khn.org/news/video-chat-in-rural-areas-combating-drug-addiction-a-new-way-to-connect-with-help/ - Xerox Open Enrollment Survey Infographic: https://www.xerox.com/en-us/services/healthcare-payers/insights/open-enrollment - The New API Economy (Now With Interoperability!!!): http://thehealthcareblog.com/blog/2016/07/27/the-new-api-economy-now-with-interoperability/ - MTV 2014 Patient Keynote: Lisa Maki, CEO PokitDok: www.youtube.com/watch?v=K4ZNlWKaDxo - Sustain or Die Manifesto: pulseandsignal.com/sustainordie/

The first guest today will be Linda Heuer, founder of 121 Benefits. Earlier this year, Linda purchased Eide Bailly Employee Benefits Services from the well-known CPA firm and introduced a new TPA to the Midwest. The company is called 121 Benefits. Heuer, a former Eide Bailly principal, had noticed that the benefits industry was becoming increasingly self-service, which runs counter to the increasing complexity that employers and individuals face when dealing with health benefits. As a result, her focus with 121 Benefits is to provide a more responsive, personal, face-to-face service experience and a high level of benefits expertise. Using her team’s first-hand knowledge of employer preferences for one-to-one service and their proven compliance leadership, the 121 Benefits team offers a fresh approach for private and public employers.The second guest on this week's show will be Bill Haber, senior director, business development for PokitDok, an API platform built to power the business of health. In this segment, Bill will discuss how PokitDok’s APIs power interoperable transactions and how that relates to health care consumerism. He will also talk about how hospital systems, digital health companies and systems integrators, to name a few, can utilize PokitDok’s platform to improve workflows, cut costs and put power in the hands of the patient.

The first guest today will be Linda Heuer, founder of 121 Benefits. Earlier this year, Linda purchased Eide Bailly Employee Benefits Services from the well-known CPA firm and introduced a new TPA to the Midwest. The company is called 121 Benefits. Heuer, a former Eide Bailly principal, had noticed that the benefits industry was becoming increasingly self-service, which runs counter to the increasing complexity that employers and individuals face when dealing with health benefits. As a result, her focus with 121 Benefits is to provide a more responsive, personal, face-to-face service experience and a high level of benefits expertise. Using her team’s first-hand knowledge of employer preferences for one-to-one service and their proven compliance leadership, the 121 Benefits team offers a fresh approach for private and public employers.The second guest on this week's show will be Bill Haber, senior director, business development for PokitDok, an API platform built to power the business of health. In this segment, Bill will discuss how PokitDok’s APIs power interoperable transactions and how that relates to health care consumerism. He will also talk about how hospital systems, digital health companies and systems integrators, to name a few, can utilize PokitDok’s platform to improve workflows, cut costs and put power in the hands of the patient.

The annual 'fall classic' aka the Health 2.0 Fall Conference convened at the Santa Clara Convention Center for it's 10th Annual gathering from September 25th - 28th, 2016. In this session Douglas Goldstein debriefs with Ted Tanner, Jr, Co-founder and CTO of Pokitdok who discusses the launch of Dokchain and more. Segment filmed and produced for Health Innovation Media by Gregg Masters, MPH. Enjoy! 

During the 2nd Annual Health 2.0 Hour at HiMSS, Matthew Holt @boltyboy catches up with @PokiDok CEO and Co-founder Lisa Maki @lisaMmaki at @HiMSS 2015. Produced by Gregg Masters @2healthguru for Health Innovation Media. This is audio only version, video to be posted to video library.